Urinary Tract Infections with Carbapenem-Resistant Klebsiella pneumoniae in a Urology Clinic—A Case-Control Study
Antibiotics · 24.06.2024 · 13 (7) · 583
DOI: 10.3390/antibiotics13070583 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift Antibiotics, online erschienen am 24.06.2024. Verfasst von Viorel Dragos Radu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The aim of our study was to analyze the factors associated with the increased risk of urinary tract infection (UTI) with carbapenem-resistant (CR) Klebsiella pneumoniae (Kpn) and the antibiotic resistance spectrum of the strains in patients. As secondary objectives, we elaborated the profile of these patients and the incidence of different types of carbapenemases.
Methods
We conducted a retrospective case-control study in which we compared a group of 62 patients with urinary tract infections with CR Kpn with a control group consisting of 136 patients with urinary tract infections with multidrug-resistant (MDR), but carbapenem-sensitive (CS), Kpn, who were hospitalized between 1 January 2022 and 31 March 2024.
Results
Compared to patients with urinary tract infections with CS Kpn, patients with urinary tract infections with CR Kpn were preponderant in rural areas (62.9% vs. 47.1%, p = 0.038) and more frequently had an upper urinary tract infection (69.4% vs. 36.8%, p < 0.01). Among the risk factors examined, patients in the study group had a higher presence of urinary catheters inserted for up to one month (50% vs. 34.6%, p = 0.03), rate of hospitalization in the last 180 days (96.8% vs. 69.9%, p < 0.01) and incidence of antibiotic therapy in the last 180 days (100% vs. 64.7%, p < 0.01). They also had a higher rate of carbapenem treatment in the last 180 days (8.1% vs. 0%, p < 0.01). Patients in the study group had a broader spectrum of resistance to all antibiotics tested (p < 0.01), with the exception of sulfamethoxazole–trimethoprim, where the resistance rate was similar in both groups (80.6% vs. 67.6%, p = 0.059). In the multivariate analysis, transfer from other hospitals (OR = 3.51, 95% and CI: 1.430–8.629) and treatment with carbapenems in the last 180 days (OR = 11.779 and 95% CI: 1.274–108.952) were factors associated with an increased risk of disease compared to the control group. The presence of carbapenemases was observed in all patients with CR Kpn, in the order of frequency New Delhi metallo-ß-lactamase (NDM) (52.2%), Klebsiella pneumoniae carbapenemase (KPC) (32.6%), and carbapenem-hydrolyzing oxacillinase (Oxa-48) (15.2%).
Conclusions
The environment of origin and previous treatment with carbapenems appear to be the factors associated with an increased risk of urinary tract infection with CR Kpn compared to patients with urinary tract infections with CS Kpn. CR Kpn exhibits a broad spectrum of antibiotic resistance, among which is resistance to carbapenem antibiotics.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
- Department of Urology and Renal Transplantation, "C.I. Parhon" University Hospital, 700115 Iasi, Romania.
- Department of Morpho-Functional Sciences II, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
- Department of Urology, Elytis Hope Hospital, 700010 Iasi, Romania.
- Department of Internal Medicine I, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
- Department of Preventive and Interdisciplinarity, Medical Informatics and Biostatistics, Faculty of Medicine, University of Medicine and Pharmacy "Gr. T. Popa", 700115 Iasi, Romania.
ORCID-Profile: Pavel Onofrei, Radu-Stefan Miftode, Lucian Vasile Boiculese, Ionela-Larisa Miftode
Zitieren
APA
Radu, V. D., Costache, R. C., Onofrei, P., Miron, A., Bandac, C. A., Arseni, D., Mironescu, M., Miftode, R. S., Boiculese, L. V., & Miftode, I. L. (2024). Urinary Tract Infections with Carbapenem-Resistant Klebsiella pneumoniae in a Urology Clinic—A Case-Control Study. Antibiotics, 13(7), 583. https://doi.org/10.3390/antibiotics13070583
Vancouver
Radu VD, Costache RC, Onofrei P, Miron A, Bandac CA, Arseni D, et al. Urinary Tract Infections with Carbapenem-Resistant Klebsiella pneumoniae in a Urology Clinic—A Case-Control Study. Antibiotics. 2024;13(7):583. doi:10.3390/antibiotics13070583
BibTeX
@article{Radu2024,
author = {Radu, Viorel Dragos and Costache, Radu Cristian and Onofrei, Pavel and Miron, Adelina and Bandac, Carina-Alexandra and Arseni, Daniel and Mironescu, Mihaela and Miftode, Radu-Stefan and Boiculese, Lucian Vasile and Miftode, Ionela-Larisa},
title = {Urinary Tract Infections with Carbapenem-Resistant Klebsiella pneumoniae in a Urology Clinic—A Case-Control Study},
journal = {Antibiotics},
year = {2024},
volume = {13},
number = {7},
pages = {583},
doi = {10.3390/antibiotics13070583}
}
EUVIMED